Risk_NN factors_NNS for_IN breast_NN cancer_NN in_IN Iran_NP :_: a_DT case-control_NN study_NN Abstract_NP |_SYM Background_NN |_SYM Iranian_JJ breast_NN cancer_NN patients_NNS are_VBP relatively_RB younger_JJR than_IN their_PP$ Western_JJ counterparts_NNS ._SENT The_DT objective_NN of_IN the_DT present_JJ study_NN was_VBD to_TO investigate_VB risk_NN factors_NNS for_IN breast_NN cancer_NN in_IN Iranian_JJ women_NNS ._SENT Method_NN |_SYM A_DT case-control_NN study_NN was_VBD conducted_VBN from_IN April_NP 1997_CD to_TO April_NP 1998_CD in_IN Tehran_NP ,_, Iran_NP ._SENT Demographical_JJ data_NNS and_CC risk_NN factor_NN related_JJ information_NN were_VBD collected_VBN using_VBG a_DT short_JJ structured_JJ questionnaire_NN ._SENT Odds_NNS ratios_NNS (_( ORs_NP )_) and_CC 95_CD %_NN confidence_NN intervals_NNS (_( CIs_NP )_) were_VBD derived_VBN from_IN logistic_JJ regression_NN analysis_NN ._SENT Results_NNS |_SYM In_IN all_DT ,_, 286_CD women_NNS with_IN breast_NN cancer_NN and_CC 249_CD control_NN women_NNS were_VBD interviewed_VBN ._SENT In_IN multivariate_JJ analysis_NN ,_, only_RB marital_JJ status_NN (_( never_RB married_JJ :_: OR_CC 4.24_CD ,_, 95_CD %_NN CI_NP 1.70-10.57_CD [_SYM P_NN =_SYM 0.002_CD ]_SYM ;_: widowed/divorced_JJ :_: OR_CC 1.71_CD ,_, 95_CD %_NN CI_NP 1.05-2.68_CD [_SYM P_NN =_SYM 0.03_CD ]_SYM )_) and_CC family_NN history_NN (_( positive_JJ family_NN history_NN of_IN breast_NN cancer_NN :_: OR_CC 2.95_CD ,_, 95_CD %_NN CI_NP 1.15-7.59_CD [_SYM P_NN =_SYM 0.02_CD ]_SYM )_) were_VBD associated_VBN with_IN significantly_RB increased_VBN risk_NN for_IN breast_NN cancer_NN ._SENT Conclusion_NN |_SYM The_DT findings_NNS of_IN the_DT present_JJ study_NN suggest_VBP that_IN family_NN history_NN and_CC marital_JJ status_NN may_MD have_VB an_DT impact_NN on_IN the_DT incidence_NN of_IN breast_NN cancer_NN in_IN Iranian_JJ women_NNS ._SENT breast_NN cancer_NN ,_, case-control_NN ,_, Iran_NP ,_, risk_NN factor_NN ,_, control_NN ,_, Iran_NP ,_, risk_NN factor_NN ,_, Introduction_NP :_: Geographical_JJ variations_NNS in_IN incidence_NN and_CC mortality_NN rates_NNS of_IN breast_NN cancer_NN suggest_VBP that_IN the_DT known_VBN risk_NN factors_NNS for_IN breast_NN cancer_NN may_MD vary_VB in_IN different_JJ parts_NNS of_IN the_DT world_NN and_CC that_IN environmental_JJ factors_NNS are_VBP of_IN greater_JJR importance_NN than_IN genetic_JJ factors_NNS ._SENT For_IN instance_NN ,_, in_IN Iran_NP it_PP has_VBZ been_VBN shown_VBN that_IN ,_, even_RB after_IN adjusting_VBG for_IN age_NN ,_, young_JJ women_NNS are_VBP at_IN relatively_RB higher_JJR risk_NN for_IN developing_VBG breast_NN cancer_NN than_IN are_VBP their_PP$ Western_JJ counterparts_NNS ._SENT Thus_RB ,_, study_NN of_IN risk_NN factors_NNS for_IN breast_NN cancer_NN in_IN Iranian_JJ women_NNS is_VBZ important_JJ and_CC might_MD contribute_VB to_TO current_JJ knowledge_NN on_IN this_DT important_JJ topic_NN ._SENT The_DT aim_NN of_IN the_DT present_JJ study_NN was_VBD to_TO examine_VB the_DT relationship_NN between_IN reproductive_JJ and_CC other_JJ risk_NN factors_NNS for_IN breast_NN cancer_NN in_IN Iranian_JJ women_NNS ._SENT A_DT case-control_NN study_NN was_VBD conducted_VBN from_IN April_NP 1997_CD to_TO April_NP 1998_CD (_( one_CD complete_JJ calendar_NN year_NN )_) in_IN Tehran_NP ,_, Iran_NP ._SENT The_DT cases_NNS were_VBD incident_NN ,_, newly_RB diagnosed_VBN breast_NN cancer_NN patients_NNS living_VBG in_IN Tehran_NP ,_, and_CC they_PP were_VBD entered_VBN into_IN the_DT study_NN if_IN they_PP had_VBD a_DT confirmed_VBN pathological_JJ breast_NN cancer_NN diagnosis_NN and_CC were_VBD admitted_VBN to_TO the_DT Imam_NP University_NP Hospital_NP (_( a_DT large_JJ teaching_NN and_CC general_JJ hospital_NN in_IN the_DT central_JJ district_NN of_IN Tehran_NP )_) for_IN breast_NN surgery_NN ._SENT The_DT control_NN women_NNS were_VBD recruited_VBN from_IN female_JJ patients_NNS living_VBG in_IN Tehran_NP without_IN any_DT history_NN of_IN breast_NN problems_NNS or_CC neoplastic_JJ disease_NN admitted_VBD to_TO the_DT same_JJ hospital_NN for_IN a_DT wide_JJ spectrum_NN of_IN general_JJ surgical_JJ procedures_NNS ._SENT Women_NNS with_IN hysterectomy_NN and_CC artificial_JJ menopause_NN were_VBD excluded_VBN from_IN the_DT study_NN ._SENT Although_IN the_DT hospital_NN does_VBZ not_RB have_VB an_DT ethics_NNS committee_NN ,_, in_IN addition_NN to_TO a_DT written_JJ permission_NN from_IN hospital_NN authorities_NNS ,_, verbal_JJ consent_NN was_VBD obtained_VBN from_IN all_DT participants_NNS ._SENT All_DT women_NNS were_VBD interviewed_VBN by_IN one_CD investigator_NN (_( MV_NP )_) ._SENT Demographical_JJ and_CC risk_NN factor_NN data_NNS were_VBD collected_VBN using_VBG a_DT short_JJ structured_JJ questionnaire_NN ,_, including_VBG information_NN on_IN age_NN ,_, educational_JJ level_NN ,_, marital_JJ status_NN ,_, family_NN history_NN of_IN breast_NN cancer_NN (_( first-degree_NN relatives_NNS )_) ,_, age_NN at_IN menarche_NN ,_, parity_NN ,_, oral_JJ contraceptive_JJ use_NN ,_, age_NN at_IN first_JJ and_CC last_JJ full-term_NN pregnancy_NN ,_, menopausal_JJ status_NN ,_, and_CC age_NN at_IN menopause_NN ._SENT Women_NNS were_VBD classified_VBN as_IN menopausal_JJ if_IN they_PP had_VBD not_RB menstruated_VBN during_IN the_DT 6_CD months_NNS before_IN the_DT date_NN of_IN data_NN collection_NN ._SENT A_DT full-term_NN pregnancy_NN was_VBD a_DT pregnancy_NN lasting_VBG 8_CD months_NNS or_CC longer_JJR ._SENT Univariate_JJ logistic_JJ regression_NN analysis_NN was_VBD performed_VBN to_TO calculate_VB odds_NNS ratios_NNS (_( ORs_NP )_) and_CC to_TO examine_VB the_DT predictive_JJ effect_NN of_IN each_DT factor_NN on_IN risk_NN for_IN breast_NN cancer_NN ._SENT P_NN <_SYM 0.05_CD was_VBD considered_VBN statistically_RB significant_JJ ._SENT Those_DT risk_NN factors_NNS that_WDT were_VBD significantly_RB associated_VBN with_IN breast_NN cancer_NN were_VBD entered_VBN into_IN a_DT forward_JJ selection_NN multivariate_JJ logistic_JJ regression_NN analysis_NN ._SENT In_IN all_DT ,_, 286_CD women_NNS with_IN breast_NN cancer_NN (_( from_IN the_DT total_NN of_IN approximately_RB 300_CD women_NNS who_WP were_VBD newly_RB diagnosed_VBN as_IN having_VBG breast_NN cancer_NN during_IN the_DT study_NN period_NN )_) and_CC 249_CD control_NN women_NNS were_VBD interviewed_VBN ._SENT The_DT mean_JJ +-_NN SD_NN age_NN of_IN cases_NNS and_CC controls_NNS was_VBD 47.5_CD +-_NN 12.5_CD years_NNS (_( range_NN 24-81_CD years_NNS )_) and_CC 44.2_CD +-_NN 13.3_CD years_NNS (_( range_NN 23-80_CD years_NNS )_) ,_, respectively_RB ._SENT There_EX were_VBD no_DT significant_JJ differences_NNS between_IN cases_NNS and_CC controls_NNS with_IN regard_NN to_TO age_VB (_( except_IN for_IN the_DT age_NN group_NN =_SYM 60_CD years_NNS )_) ,_, educational_JJ level_NN ,_, age_NN at_IN menarche_NN ,_, past_JJ oral_JJ contraceptive_JJ use_NN ,_, age_NN at_IN first_JJ and_CC last_JJ full-term_NN pregnancy_NN ,_, and_CC age_NN at_IN menopause_NN ._SENT The_DT results_NNS of_IN univariate_JJ logistic_JJ regression_NN analysis_NN are_VBP shown_VBN in_IN Table_NP ._SENT Compared_VBN with_IN married_JJ women_NNS ,_, never_RB married_JJ women_NNS were_VBD at_IN higher_JJR risk_NN for_IN breast_NN cancer_NN (_( OR_NP 4.25_CD ,_, 95_CD %_NN confidence_NN interval_NN [_SYM CI_NP ]_SYM 1.71-10.57_CD )_) ._SENT Breast_NN cancer_NN risk_NN was_VBD significantly_RB greater_JJR in_IN women_NNS with_IN a_DT family_NN history_NN of_IN the_DT disease_NN (_( OR_NP 2.87_CD ,_, 95_CD %_NN CI_NP 1.13-7.30_CD )_) and_CC in_IN nulliparous_JJ women_NNS (_( OR_NP 2.78_CD ,_, 95_CD %_NN CI_NP 1.45-5.35_CD )_) ._SENT However_RB ,_, other_JJ variables_NNS did_VBD not_RB exhibit_VB a_DT significant_JJ association_NN with_IN breast_NN cancer_NN except_IN for_IN age_NN 60_CD years_NNS or_CC older_JJR (_( OR_NP 1.87_CD ,_, 95_CD %_NN CI_NP 1.13-3.10_CD )_) ._SENT Table_NP 1_CD |_SYM Risk_NN factors_NNS for_IN breast_NN cancer_NN derived_VBN from_IN univariate_JJ analysis_NN On_IN multivariate_JJ analysis_NN ,_, in_IN addition_NN to_TO those_DT factors_NNS that_WDT were_VBD found_VBN to_TO carry_VB a_DT significant_JJ association_NN with_IN breast_NN cancer_NN in_IN the_DT initial_JJ analysis_NN ,_, age_NN was_VBD also_RB included_VBN ._SENT This_DT was_VBD done_VBN because_IN ,_, although_IN the_DT study_NN was_VBD not_RB an_DT age-matched_JJ case-control_NN study_NN ,_, older_JJR age_NN exhibited_VBD a_DT significant_JJ association_NN on_IN univariate_JJ analysis_NN ._SENT The_DT final_JJ model_NN indicated_VBD that_IN only_JJ marital_JJ status_NN (_( never_RB married_JJ :_: OR_CC 4.24_CD ,_, 95_CD %_NN CI_NP 1.70-10.57_CD [_SYM P_NN =_SYM 0.002_CD ]_SYM ;_: widowed/divorced_JJ :_: OR_CC 1.71_CD ,_, 95_CD %_NN CI_NP 1.05-2.68_CD [_SYM P_NN =_SYM 0.03_CD ]_SYM )_) and_CC family_NN history_NN of_IN breast_NN cancer_NN (_( positive_JJ family_NN history_NN :_: OR_CC 2.95_CD ,_, 95_CD %_NN CI_NP 1.15-7.59_CD [_SYM P_NN =_SYM 0.02_CD ]_SYM )_) were_VBD significantly_RB associated_VBN with_IN breast_NN cancer_NN ,_, and_CC that_DT nulliparity_NN and_CC older_JJR age_NN were_VBD not_RB significant_JJ risk_NN factors_NNS for_IN breast_NN cancer_NN ._SENT Breast_NN cancer_NN patients_NNS in_IN Iran_NP are_VBP relatively_RB young_JJ ,_, and_CC the_DT findings_NNS presented_VBD here_RB suggest_VB that_DT marital_JJ status_NN and_CC a_DT positive_JJ family_NN history_NN of_IN breast_NN cancer_NN are_VBP risk_NN factors_NNS for_IN breast_NN cancer_NN in_IN Iran_NP ._SENT This_DT is_VBZ in_IN accordance_NN with_IN other_JJ research_NN findings_NNS indicating_VBG that_IN a_DT positive_JJ family_NN history_NN of_IN breast_NN cancer_NN is_VBZ a_DT strong_JJ risk_NN factor_NN for_IN breast_NN cancer_NN at_IN young_JJ age_NN ,_, although_IN this_DT has_VBZ a_DT comparatively_RB small_JJ effect_NN on_IN the_DT absolute_JJ lifetime_NN incidence_NN of_IN and_CC mortality_NN from_IN breast_NN cancer_NN ._SENT However_RB ,_, with_IN regard_NN to_TO the_DT findings_NNS from_IN the_DT present_JJ study_NN ,_, one_PP may_MD argue_VB that_IN the_DT relatively_RB high_JJ proportion_NN of_IN young_JJ breast_NN cancer_NN cases_NNS in_IN Iran_NP is_VBZ most_RBS likely_RB due_JJ a_DT to_TO a_DT young_JJ population_NN structure_NN and_CC to_TO a_DT combination_NN of_IN high_JJ age_NN at_IN menarche_NN and_CC low_JJ age_NN at_IN first_JJ pregnancy_NN ,_, which_WDT are_VBP protective_JJ in_IN later_JJR life_NN ._SENT Evidence_NN from_IN the_DT USA_NP also_RB suggests_VBZ that_IN ,_, in_IN some_DT Asian_JJ subgroups_NNS such_JJ as_IN the_DT Vietnamese_NNS ,_, women_NNS diagnosed_VBD with_IN breast_NN cancer_NN tend_VBP to_TO be_VB younger_JJR than_IN those_DT from_IN other_JJ racial_JJ or_CC ethnic_JJ groups_NNS ,_, with_IN half_NN of_IN the_DT diagnoses_NNS occurring_VBG in_IN women_NNS younger_JJR than_IN 50_CD years_NNS ;_: this_DT needs_VBZ further_JJR exploration_NN ._SENT The_DT findings_NNS presented_VBD here_RB show_VB that_IN never_RB married_JJ women_NNS were_VBD at_IN higher_JJR risk_NN for_IN breast_NN cancer_NN ._SENT In_IN most_JJS studies_NNS single_JJ and_CC nulliparous_JJ married_JJ women_NNS were_VBD found_VBN to_TO have_VB a_DT similar_JJ increased_VBN risk_NN for_IN breast_NN cancer_NN as_IN compared_VBN with_IN parous_JJ women_NNS of_IN the_DT same_JJ age_NN ._SENT Thus_RB ,_, one_PP may_MD argue_VB that_DT marital_JJ status_NN by_IN itself_PP is_VBZ not_RB a_DT determining_VBG factor_NN for_IN increased_VBN or_CC reduced_VBN breast_NN cancer_NN risk_NN ,_, and_CC rather_RB the_DT main_JJ protective_JJ effect_NN is_VBZ from_IN early_JJ first_JJ full-term_NN pregnancy_NN ._SENT However_RB ,_, in_IN the_DT present_JJ study_NN no_DT association_NN with_IN parity_NN emerged_VBD when_WRB multivariate_JJ analysis_NN was_VBD performed_VBN ._SENT Evidence_NN suggests_VBZ that_IN there_EX is_VBZ an_DT interaction_NN between_IN marital_JJ status_NN and_CC parity_NN ,_, supporting_VBG a_DT '_'' dual_JJ effect_NN '_'' of_IN parity_NN on_IN breast_NN cancer_NN risk_NN with_IN pregnancy_NN ._SENT Studies_NNS have_VBP shown_VBN that_IN interactions_NNS between_IN age_NN ,_, family_NN history_NN of_IN breast_NN cancer_NN and_CC parity_NN might_MD exist_VB ._SENT In_IN addition_NN ,_, studies_NNS have_VBP reported_VBN that_IN nulliparity_NN reduces_VBZ risk_NN for_IN breast_NN cancer_NN at_IN younger_JJR age_NN and_CC elevates_VBZ risk_NN in_IN the_DT elderly_JJ ._SENT The_DT lack_NN of_IN significant_JJ associations_NNS between_IN breast_NN cancer_NN and_CC the_DT other_JJ variables_NNS studied_VBN was_VBD unexpected_JJ ._SENT For_IN example_NN ,_, studies_NNS have_VBP shown_VBN that_IN past_JJ oral_JJ contraceptive_JJ use_NN is_VBZ associated_VBN with_IN a_DT somewhat_RB higher_JJR OR_NN among_IN young_JJ women_NNS or_CC women_NNS who_WP have_VBP a_DT family_NN history_NN of_IN breast_NN cancer_NN ._SENT However_RB ,_, although_IN there_EX were_VBD clear_JJ patterns_NNS in_IN ORs_NNS for_IN most_JJS variables_NNS ,_, we_PP suspect_VBP that_IN this_DT lack_NN of_IN significant_JJ associations_NNS may_MD be_VB explained_VBN by_IN the_DT limited_JJ power_NN of_IN the_DT present_JJ study_NN to_TO estimate_VB risk_NN ._SENT Finally_RB ,_, one_PP should_MD be_VB aware_JJ of_IN the_DT limitations_NNS of_IN the_DT present_JJ study_NN ,_, including_VBG case_NN and_CC control_NN ascertainment_NN and_CC representation_NN ._SENT Although_IN the_DT results_NNS cannot_MD be_VB generalized_VBN ,_, the_DT findings_NNS suggest_VBP that_IN the_DT associations_NNS between_IN some_DT known_VBN risk_NN factors_NNS for_IN breast_NN cancer_NN may_MD differ_VB in_IN Iran_NP as_IN compared_VBN with_IN Western_JJ countries_NNS ,_, and_CC that_DT familial_JJ breast_NN cancer_NN in_IN young_JJ Iranian_JJ breast_NN cancer_NN patients_NNS deserves_VBZ further_JJR investigation_NN ._SENT CI_NN =_SYM confidence_NN interval_NN ;_: OR_NP =_SYM odds_NN ratio_NN ._SENT 